Green Circle Health's client services center will provide remote health care and coaching for customers across the country, focusing in part on improving the coordination of care for chronic diseases.
A small Carmel-based biotech firm has signed a deal with international drug company Allergan Plc that is worth at least $50 million and could grow to more than $2 billion under the best-case scenario.
More than 167,000 Indiana residents have signed up for health insurance under the Affordable Care Act.
Newly-inaugurated Indiana Gov. Eric Holcomb made good on his plan to establish a drug czar position Monday when he signed an executive order on his first official day in office.
The Indiana General Assembly is back in session and set to consider all manner of health care legislation, from consumer rights to expanded insurance coverage.
VCA operates more than 750 animal hospitals in the United States, including about 10 in the Indianapolis area.
The U.S.’s biggest health insurer, UnitedHealth Group Inc., said it will buy Surgical Care Affiliates Inc. for about $2.3 billion, further diversifying by adding an outpatient surgery chain.
An Indianapolis physician whose patients were told at multiple CVS Pharmacy stores that their prescriptions couldn’t be filled because the doctor had been arrested or was suspected of running a "pill mill" won a defamation judgment against the drugstore chain.
Alex Azar, president of Lilly USA LLC since 2012, is leaving the company just as his unit is about to lose a huge swath of sales personnel. The drugmaker announced a series of changes Thursday under new CEO David Ricks.
Riley is spending millions of dollars and beefing up its emergency staff to expand into traditional emergency services.
Republicans are united on repealing President Barack Obama's health care law, but ideologically and practically speaking, they're in different camps over replacing it.
The executive director at White River State Park is fighting her way back from a ruptured brain aneurysm, a condition that leaves many of its victims disabled, or worse.
Federal prosecutors say two American Senior Communities executives and two other men orchestrated a scheme that used kickbacks and shell companies to defraud American Senior Communities and federal health care programs out of millions of dollars.
t was the most closely watched experimental drug from Eli Lilly and Co. in years, a potential game-changer for treating the ravages of Alzheimer’s disease.
Anthem Inc. and the U.S. Justice Department extended their clash over whether the insurer’s planned takeover of rival Cigna Corp. will raise costs.
The move by Mainscape founder Dave Mazanowski, disclosed in a federal court filing, is potentially problematic for the four other executives charged this fall.
Eli Lilly and Co. shares rose sharply Thursday morning after the company presented a better-than-expected 2017 forecast nearly a month after it had announced the failure of a key Alzheimer’s treatment in testing.
The company’s announcement reassured investors in the wake of last month’s news that the Alzheimer’s drug solanezumab had failed to demonstrate effectiveness during a large-scale clinical trial.
The point of chemo is to cure me. But these are not gentle chemicals. They sweep through my body like a tornado, with side effects that range from annoying to horrendous. But I have no choice.
Eli Lilly and Co. will bypass insurance companies to offer a discount on its best-selling insulin products for patients who lack health coverage or have high deductibles that require them to pay the full cost of some medications.
